About Us

Our Transformative Platform
for First-in-Class Medicines

At Abide Therapeutics, we have the platform and the people to become the world leader in realizing the therapeutic value of novel serine hydrolase inhibitors to transform the lives of patients with serious unmet medical needs.

Serine hydrolases are an under-explored class of enzymes that are relevant in many diseases, playing key roles in disease areas such as CNS, inflammation, and metabolism. By combining a broad serine hydrolase activity assay with a proprietary, tailored chemical library, Abide's discovery platform allows us to efficiently identify, characterize, and develop of new, highly selective small-molecule inhibitors of individual serine hydrolases.

Meet the Leaders of Our Distinguished Team

Our team of world-class scientists shares a deep commitment to our cultural values of courage, integrity, and excellence. We are driven by knowing that the work we do today will change patients’ lives tomorrow. Our byword is “Every Day Is the Most Important Day.”

Our team has a proven track record of translating biology to successful products. The development of our lead candidate ABX-1431, which was identified and brought to the clinic in under three years, demonstrates both the power of our platform and the commitment of our team to our shared mission. We are honored to work with a Scientific Advisory Board of distinguished scientists, clinicians, and drug discovery experts, including two Nobel Laureates.

Leadership Team
Board of Directors
Scientific Advisory Board
Investor 1

With over $300 million under management, Cardinal Partners is a leading early-stage venture capital firm that seeks investment opportunities across the healthcare sector including life sciences, medical devices, and healthcare information technology.

Cardinal’s management team leverages their decades of experience to nurture today’s enterprises into tomorrow’s industry leaders. Together, the Cardinal Partners team has invested in over a hundred growth companies. Cardinal Partners is based in Princeton, New Jersey and also has offices in Laguna Beach, California and Wayne, Pennsylvania.

Strategic Partnerships and Collaborations

Since Abide’s inception in 2011, we have formed alliances with top-tier pharmaceutical and biotechnology companies as well as leading academic laboratories and research foundations. We have a continuing interest in collaborating with partners who have unique biological expertise and capabilities in therapeutic areas where modulation of serine hydrolases can play a role in treating diseases with serious unmet medical need.

Select a partner to find out more.

Partner logo
Partner logo
Partner logo